COMP <GO>
HNGE vs TSM // RETURN ON INVESTED CAPITAL (ROIC)
Hinge Health Inc. (NYSE) VS. Taiwan Semiconductor Manufacturing Company Ltd. (NYSE) • 15-METRIC TALLY: HNGE 5
— TSM 7
▲ RETURN ON INVESTED CAPITAL (ROIC) LEADER: TSM
LAST: $114.32 (-2.21%) • MKT CAP: $9.43B
roic
-35.00%
LAST: $406.13 (-5.95%) • MKT CAP: $2.24T
roic
14.90%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HNGE VS. TSM)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HNGE | TSM | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 79.60% | 62.00% | +17.60 | HNGE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) ACTIVE | -35.00% | 14.90% | -49.90 | TSM | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | 14.9x | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | 1.81% | 3.99% | -2.18 | TSM | /fcf-yield <GO> |
| Operating Margin | -60.00% | 21.10% | -81.10 | TSM | /operating-margins <GO> |
| Net Profit Margin | -60.00% | 16.40% | -76.40 | TSM | /net-margins <GO> |
| Revenue Growth (YoY) | 50.60% | -3.30% | +53.90 | HNGE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.12 | 3.87 | +8.25 | HNGE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.70% | 8.30% | -0.60 | HNGE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 67.5 | 38.3 | +29.16 | HNGE | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.24 | 1.42 | -0.18 | TSM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.0x | 20.2x | +8.80 | TSM | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $9.43B | $2.24T | -$2.23T | TSM | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HNGE REV | TSM REV | HNGE GROSS % | TSM GROSS % | HNGE FCF | TSM FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $587.9M | — | 79.6% | — | $170.7M | — |
| FY 2024 | $390.4M | — | 76.8% | — | $48.0M | — |
| FY 2023 | $292.7M | — | 44.0% | — | -$77.1M | — |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HNGE // BETA 1.24
TSM // BETA 1.42